We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Arthroscopic Surgery More Successful in Active Patients

By HospiMedica staff writers
Posted on 24 Mar 2008
A new study has found that for highly active first-time shoulder dislocation patients, arthroscopic surgery yielded excellent long-term benefit when compared to conservative methods.

Researchers at the Keller Army Hospital (West Point, NY, USA) and the Williams Beaumont Army Medical Center (El Paso, TX, USA) evaluated 39 patients (with a total of 40 shoulder operations) whose follow-up averaged 11.7 years. More...
Patients were evaluated with patient-derived outcome measures and asked to compare their repaired shoulder to its function level pre-injury and whether they would be likely to have the surgery again. Additionally, they were physically assessed with a number of tests, including how many push-ups they completed in two minutes and performance on the Army Physical Fitness Test.

The study results found that overall, the patients maintained excellent use of their shoulder. The patients compared their repaired shoulders' function to the pre-injury function, with the average response at 93%. When responding to whether they would have the surgery again, the average score was 9.1 out of 10. In terms of athletic ability, the study found the average number of push-ups performed in 2 minutes was 72.8, compared to 77.7 prior to their injuries. The mean score of the Army Physical Fitness Test was 282.2 out of a possible 300. The study also noted five patients who had eight further dislocations, all of which occurred during athletic activity, for a failure rate of 10% long-term. The study results were presented at the 2008 American Orthopaedic Society for Sports Medicine Specialty Day, held during March 2008 in San Francisco (CA, USA).

"Certainly our study proves that for this group of patients, young, athletic cadets unable to modify their activity level, arthroscopic surgery for first-time dislocations is successful both short and long-term,” said co-author Major Brett Owens, M.D., of the Beaumont Army Medical Center. "This treatment allowed our patients to return to sports, graduate from the military academy and engage in active duty military obligations. It may not be the approach that should be taken for a person who lives a sedentary lifestyle, but this could be applicable to the young, 15-25-year-old athlete, who is at high risk for recurrent instability and compromised function.”


Related Links:
Keller Army Hospital
Williams Beaumont Army Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.